People · Operator
Named in public records as an officer, director or promoter · active 2012–2025 · Other Health Care, Biotechnology, Medical Devices
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tenaxis Medical Inc | — | Other Health Care | Series A | $43.1M | $27.8M | 2012 |
| Neurolutions Inc | — | Biotechnology | Series B | $26.5M | $144.9M | 2025 |
| Tally Surgical, Inc. | — | Medical Devices | Series A | $11.6M | $38.8M | 2022 |
Stavros Vizirgianakis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stavros Vizirgianakis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Amarpreet Sawhney | 1 | 8 |
| Kevin Reilly | 1 | 5 |
| Stephen Moore | 1 | 4 |
| Erin McGurk | 1 | 3 |
| David Dreyer | 1 | 3 |
| Jason Grimes | 1 | 3 |
| Greg Vontz | 1 | 3 |
| Leo Petrossian | 1 | 3 |
| Fred Khosravi | 1 | 2 |
| John Holcomb | 1 | 2 |
| John Hendrick | 1 | 2 |
| Brian Stewart | 1 | 2 |
| William Cohn | 1 | 2 |
| David W.J. Smith | 1 | 1 |
| Yuanwei Tai | 1 | 1 |
| Eric Leuthardt | 1 | 1 |
| Ronald Dieck | 1 | 1 |
| Stephen Inacker | 1 | 1 |
| David A. Dreyer | 1 | 1 |
| Stephen A. Inacker | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.